LONDON – MyHealthChecked PLC (AIM: MHC), a UK-based consumer home-testing healthcare company, has announced the issuance of 30,000 new ordinary shares following the exercise of options. The shares, each with a nominal value of 1.5p, were allotted on Monday, December 20, 2024, under the company’s existing allotment authorities.

The options were exercised at a price of 9.5 pence per share. The new ordinary shares are expected to be admitted to trading on the London Stock Exchange (LON:)’s AIM market at 8.00 am on or around December 31, 2024, and will rank equally in all respects with the existing ordinary shares of the company.

Following the admission of the new shares, MyHealthChecked’s total issued share capital will consist of 52,035,932 ordinary shares. Consequently, the total number of voting rights in the company will also be 52,035,932, which shareholders can use as the denominator for calculations related to their interest notifications under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

MyHealthChecked specializes in a variety of at-home healthcare and wellness tests. Their portfolio includes lateral-flow self-tests and sample collection kits for DNA, RNA, and blood, which are analyzed by partner laboratories. These products aim to cater to a growing market of consumers seeking accessible healthcare options.

The company has made its products available online and for over-the-counter purchase, positioning itself within the evolving at-home testing kit market that emphasizes affordability and expertise from UK-based professionals.

This development is based on a press release statement and reflects the company’s ongoing efforts to manage its share capital effectively. The information provided does not imply an endorsement of the company’s market position or future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.